Mercer Global Advisors Inc Kiniksa Pharmaceuticals, Ltd. Transaction History

Mercer Global Advisors Inc

  • $43 Billion
  • Q1 2025

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$17.63 - $21.74 $19,304 - $23,805
-1,095 Reduced 5.83%
17,689 $349,000
Q4 2023

Feb 14, 2024
BUY
$14.37 - $19.07 $23,365 - $31,007
1,626 Added 9.48%
18,784 $329,000
Q3 2023

Nov 13, 2023
SELL
$13.62 - $20.2 $82,618 - $122,533
-6,066 Reduced 26.12%
17,158 $298,000
Q2 2023

Aug 14, 2023
BUY
$10.44 - $16.48 $52,805 - $83,355
5,058 Added 27.84%
23,224 $326,000
Q1 2023

May 15, 2023
BUY
$10.7 - $15.79 $194,376 - $286,841
18,166 New
18,166 $195,000

Others Institutions Holding KNSA

# of Institutions
7
Shares Held
1.9M
Call Options Held
0
Put Options Held
0
View Full List

About Kiniksa Pharmaceuticals, Ltd.

KNSA Quotes by TradingView
  • Ticker KNSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,470,400
  • Market Cap $953M
  • Description
  • Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...
More about KNSA
Track This Portfolio

Track Mercer Global Advisors Inc Portfolio

Follow Mercer Global Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email